Helix Nanotechnologies
YC W17 · Active · Next-generation mRNA platform to solve cancer, COVID and climate.
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
 GamgeeShared: genomics, biotech, mrnaActiveAI | AI | Active | YCS26 |
 InvitrisShared: nanotechnology, biotech, cancerActiveOther | Other | Active | YCW23 |
 Kernal BiologicsShared: genomics, biotech, mrnaActiveAI | AI | Active | YCS20 |
 Persist AIShared: nanotechnology, cancer, downActiveAI | AI | Active | YCW23 |
 BiocartesianShared: biotech, biology, seeActiveOther | Other | Active | YCS24 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
 Output BiosciencesShared: biotech, biology, drug discovery and deliveryActiveAI | AI | Active | YCS21 |
 Pardes BiosciencesShared: biotech, covid, drug discovery and deliveryPublicOther | Other | Public | YCS20 |
 Talus BioShared: genomics, biotech, experimentActiveOther | Other | Active | YCS21 |
 CircumventShared: genomics, biotech, solveActiveOther | Other | Active | YCS18 |
 Shield BioShared: nanotechnology, genomics, solveInactiveOther | Other | Inactive | YCS16 |
Also from W17 in AI
All of W17
About Helix Nanotechnologies
Technology finds information and delivers physical products to us almost instantly. mRNA does the same for biology. At HelixNano, we see a world where treatments are cheap, progress is decentralized, and you can modify biology at the push of a button. By focusing on mRNA improvements from first principles, we’re getting there faster than we thought. Experiments that used to take months or years can be done in weeks and cost thousands instead of millions. The rate limiting step for our progress is now scientific curiosity. Rigid hierarchies and top-down decisions will miss the magic. Some of our most powerful technologies started out as side projects of junior team members. At HelixNano, every individual scientist can have a massive impact on the company's direction. And the more diverse our team, the faster we’ll find the really cool ideas. We've started rolling out some of our new tech — moving a COVID-19 vaccine candidate for the immunocompromised towards the clinic, and testing an intervention with massive environmental impact. But we’re scientists at heart, and team focus is solidly on the horizon.
- YC batch
- W17 · Winter 2017
- Status, per YC
- Active
- Category
- AI
- Team size
- 22
- Location
- Boston, MA, USA; Cambridge, MA, USA
- Checked
- 1h ago
YC tags: Artificial Intelligence, Biotech, Genomics, Nanotechnology
Helix Nanotechnologies: questions
Which YC batch was Helix Nanotechnologies in?
Helix Nanotechnologies was in Y Combinator's Winter 2017 batch (W17).
Is Helix Nanotechnologies still active?
Y Combinator lists Helix Nanotechnologies as active.
Where is Helix Nanotechnologies based?
Helix Nanotechnologies lists Boston, MA, USA; Cambridge, MA, USA as its location on YC's directory.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.